11. Stockholders' Equity |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity |
Note 11 – Stockholders’ Equity
Shares authorized
Upon formation the total number of shares of all classes of stock which the Company is authorized to issue is seventy-five million (75,000,000) shares of common stock, par value $0.001 per share.
Common stock
As of September 30, 2019 the Company had 40,959,741 shares of common stock issued and outstanding.
During the three months ended September 30, 2019, the Company did not have any transaction in its common stock
During the nine months ended September 30, 2018, the Company had the following transactions in its common stock:
Shares issued for acquisition of AVX: 39,286 shares
Shares issued for compensation: 13,445 shares
Stock options
On August 6, 2019, each member of the Board was granted 30,000 options to purchase shares at $5.70 per share. As of September 30, 2019, there were 2,100,000 outstanding stock options. There were no outstanding stock options as of December 31, 2018.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||